A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2002
12/04/2002	EP1261640A2 Inflammation-related gene
12/04/2002	EP1261639A2 Chondromodulin-i related peptide
12/04/2002	EP1261636A2 Human protein kinases and protein kinase-like enzymes
12/04/2002	EP1261635A1 Human polynucleotides, polypeptides, and antibodies
12/04/2002	EP1261606A1 Substituted oxazolidinones and their use in the field of blood coagulation
12/04/2002	EP1261605A1 Benzoxazole derivatives as tnf and pde iv inhibitors
12/04/2002	EP1261601A1 Substituted indoles for modulating nfkb activity
12/04/2002	EP1261600A1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
12/04/2002	EP1261595A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
12/04/2002	EP1261590A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
12/04/2002	EP1261586A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use
12/04/2002	EP1261583A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/04/2002	EP1261379A2 Genetic modification of the lung as a portal for gene delivery
12/04/2002	EP1261361A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1
12/04/2002	EP1261337A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
12/04/2002	EP1261336A2 Il-8 receptor antagonists
12/04/2002	EP1261330A2 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals
12/04/2002	EP1261329A2 Il-8 receptor antagonists
12/04/2002	EP1261328A1 Il-8 receptor antagonists
12/04/2002	EP1180026B1 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
12/04/2002	EP1131304B1 N- 4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
12/04/2002	EP1097139B1 Quinoline derivatives
12/04/2002	EP1054671B1 New use of ropivacaine for pain management
12/04/2002	EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/04/2002	EP0928291B1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
12/04/2002	EP0719285B1 Il8 inhibitors
12/04/2002	CN1383450A Antibody molecules having specificity for huamn tumor necrosis factory alpha, and use thereof
12/04/2002	CN1383381A Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives
12/04/2002	CN1382486A Fengshitongluo wan for treating rheumatism
12/04/2002	CN1382485A Medicine for treating lumbar intervertebral disk protrusion and its preparing process
12/04/2002	CN1382478A Extract of mulberry twig and its extracting process and novel usage
12/04/2002	CN1382466A Bone setting machine
12/04/2002	CN1382465A 'Wugu' recovery ointment
12/04/2002	CN1382464A Medicine for treating cervical vertebra disease and its preparing process
12/04/2002	CN1382462A Plaster for treating rheumatic or rheumatoid arthritis and its preparing process
12/04/2002	CN1382459A Chinese-medicinal capsule for treating rheumatic or rheumatoid arthritis and its preparing process
12/04/2002	CN1382456A Chinese medicine for treating hyperosteogeny and osteophyte
12/04/2002	CN1382455A Composite medicine for treating hyperosteogeny and its preparing process
12/04/2002	CN1095372C Chinese medicinal preparation for treating rheumatism and atrophic arthritis, and its prepn. method
12/04/2002	CN1095371C Capsule for treating bone diseases
12/03/2002	WO2001096365A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
12/03/2002	US6489445 Polypeptides which specifically bind to at least one human bone morphogenic protein (bmp) selected from bmp-5 and bmp-6
12/03/2002	US6489353 Antiinflammatory agents; autoimmune diseases; central nervous system disorders
12/03/2002	US6489340 Macrolide compounds for inducing chondrogenic differentiation
12/03/2002	US6489339 C3A receptor ligands
12/03/2002	US6489333 Heterocyclic compounds containing a guanidine mimic, for inhibition of cell adhesion, treatment of angiogenesis disorders, inflammation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration
12/03/2002	US6489332 A1 adenosine receptor antagonists
12/03/2002	US6489328 Heterocyclic compounds useful as inhibitors of tyrosine kinases
12/03/2002	US6489327 Tryptase inhibitors
12/03/2002	US6489324 Piperazine compounds as inhibitors of MMP or TNF
12/03/2002	US6489323 Inhibiting no production from l-arginine, as seen in disease states such as arthritis and systemic hypotension associated with septic and/or toxic shock
12/03/2002	US6489315 Cyclic compounds, their production and use
12/03/2002	US6489294 Truncated insulin-like growth factor binding protein-5 having mitogenic activity
12/03/2002	US6488960 Corticosteroid formulation
12/03/2002	CA2414000A1 Pyridin-2-ylaminoalkylcarbonylglycyl-beta-alanine and derivatives
12/03/2002	CA2283915C The use of alkyl hydrogen fumarates for treating psoriasis, psoriatic arthritis, neurodermatitis and enteritis regionalis crohn
12/03/2002	CA2206837C Use of strontium salts to obtain pharmaceutical compositions intented for the treatment of arthrosis
12/03/2002	CA2074933C Thiazole derivatives as active superoxide radical inhibitors
12/03/2002	CA2065644C Pyrazolopyridine compound and processes for preparation thereof
11/2002
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095034A2 A retinoic acid metabolizing cytochrome p450
11/28/2002	WO2002095012A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/28/2002	WO2002095011A2 Inactivation of genes of the mep pathway
11/28/2002	WO2002094881A2 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/28/2002	WO2002094875A1 HAb18G/CD147, IT'S AGONIST AND APPLICATION
11/28/2002	WO2002094842A2 Control of myogenesis by modulation of p38 map kinase activity
11/28/2002	WO2002094833A1 Novel pyrrole derivatives as pharmaceutical agents
11/28/2002	WO2002094824A1 Pyridopyrimidine compounds and their uses
11/28/2002	WO2002094823A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
11/28/2002	WO2002094821A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	WO2002094813A1 Novel pyridyl cyanoguanidine compounds
11/28/2002	WO2002094811A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094810A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094795A1 4-aminopyrimidine derivatives
11/28/2002	WO2002094789A1 Quinoline derivatives as ligands for the neuropeptide y receptor
11/28/2002	WO2002094788A1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
11/28/2002	WO2002094786A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002	WO2002094783A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002	WO2002094754A1 Vitamin d analogues
11/28/2002	WO2002094342A2 Compositions for protein delivery via the pulmonary route
11/28/2002	WO2002094321A1 Compositions for promoting healing of bone fracture
11/28/2002	WO2002094320A1 Therapeutic compositions for repairing chondropathy
11/28/2002	WO2002094304A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
11/28/2002	WO2002094301A1 Herbal drug composition for cartilage protection
11/28/2002	WO2002094296A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/28/2002	WO2002094294A1 A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation
11/28/2002	WO2002094287A2 Identifying parasitic fungi of the organism, and treatment thereof
11/28/2002	WO2002094268A1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
11/28/2002	WO2002094267A1 Pharmaceutical composition for prevention or treatment of arthritis
11/28/2002	WO2002094266A1 Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity
11/28/2002	WO2002094263A2 Caspase inhibitors and uses thereof
11/28/2002	WO2002094220A1 Liquid pharmaceutical composition
11/28/2002	WO2002094203A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002	WO2002094202A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
11/28/2002	WO2002094192A2 Antibodies against tumor necrosis factor delta (april)
11/28/2002	WO2002094186A2 Urazole compounds useful as anti-inflammatory agents
11/28/2002	WO2002094180A2 Pharmaceutically active isoindoline derivatives
11/28/2002	WO2002083712A8 Transporters and ion channels
11/28/2002	WO2002080887A3 Timed pulse release composition
11/28/2002	WO2002072631A8 Mhc molecule constructs and their usesfor diagnosis and therapy

1 ... 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 ... 820